Treatment of pheochromocytoma with dilevalol.
Dilevalol, an alpha- and beta-blocking agent, has been evaluated in two patients with pheochromocytoma. Dilevalol could be a useful agent for the treatment of pheochromocytoma, especially for the adrenaline-dominant type.
D000284:Administration, Oral; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D007741:Labetalol / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D010673:Pheochromocytoma / Q000188:drug therapy*
D007741:Labetalol